Literature DB >> 17106161

Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy.

Katsunobu Yoshioka1, Rie Nagata, Mami Ueda, Toshimasa Yamaguchi, Yoshio Konishi, Masayuki Hosoi, Takeshi Inoue, Kazuhiro Yamanaka, Yoshiyasu Iwai, Toshihiko Sato.   

Abstract

A 45-year-old man was admitted to our hospital because of bone pain and hypophosphatemia. He had undergone surgery 2 years previously for a "benign unclassified mesenchymal tumor" in the skull, but there were no clinical symptoms related to osteomalacia. His laboratory examination revealed low serum phosphate, high alkaline phosphatase, and normal calcium levels. The diagnosis of tumor-induced osteomalacia due to phosphaturic mesenchymal tumor mixed connective tissue variant (PMTMCT) was made by re-examining the pathologic specimens. Oral supplementation with phosphate and 1-25-dihydroxyvitamin D relieved his clinical symptoms and laboratory values returned to normal. However, subcutaneous administration of octreotide had no clinical effect. Clinicians and pathologists should be aware of the existence of PMTMCT especially nonphosphaturic or asymptomatic variants of this disorder.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17106161     DOI: 10.2169/internalmedicine.45.1797

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  7 in total

1.  Tumor-Induced Osteomalacia.

Authors:  Rajiv Kumar; Andrew L Folpe; Brian P Mullan
Journal:  Transl Endocrinol Metab       Date:  2015

Review 2.  Tumor-induced osteomalacia.

Authors:  William H Chong; Alfredo A Molinolo; Clara C Chen; Michael T Collins
Journal:  Endocr Relat Cancer       Date:  2011-06-08       Impact factor: 5.678

3.  Phosphaturic mesenchymal tumor: two contrasting cases.

Authors:  Monica C Koplas; Brian P Rubin; Murali Sundaram
Journal:  Skeletal Radiol       Date:  2014-01-09       Impact factor: 2.199

Review 4.  Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.

Authors:  Fang-Ke Hu; Fang Yuan; Cheng-Ying Jiang; Da-Wei Lv; Bei-Bei Mao; Qiang Zhang; Zeng-Qiang Yuan; Yan Wang
Journal:  Chin J Cancer       Date:  2011-11

5.  Malignant phosphaturic mesenchymal tumor with pulmonary metastasis: A case report.

Authors:  Shui Qiu; Li-Li Cao; Yue Qiu; Ping Yan; Zi-Xuan Li; Jiang Du; Li-Mei Sun; Qing-Fu Zhang
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series.

Authors:  Luisella Cianferotti; Chiara Delli Poggi; Francesco Bertoldo; Carla Caffarelli; Chiara Crotti; Davide Gatti; Sandro Giannini; Stefano Gonnelli; Maurizio Mazzantini; Viapiana Ombretta; Stefania Sella; Angela Setti; Massimo Varenna; Francesca Zucchi; Maria Luisa Brandi
Journal:  Endocrine       Date:  2022-04-05       Impact factor: 3.925

7.  Tumor induced osteomalacia in head and neck region: single center experience and systematic review.

Authors:  Ravikumar Shah; Anurag R Lila; Ramteke-Swati Jadhav; Virendra Patil; Abhishek Mahajan; Sushil Sonawane; Puja Thadani; Anil Dcruz; Prathamesh Pai; Munita Bal; Subhada Kane; Nalini Shah; Tushar Bandgar
Journal:  Endocr Connect       Date:  2019-10       Impact factor: 3.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.